Cargando…
Face masks and nanotechnology: Keep the blue side up
Coronavirus Disease 2019 (COVID-19) is one of the biggest challenges of the 21st century. While researchers are working on vaccine development and elucidating the mechanism of action and evolution of the harmful SARS-CoV-2, the current most important public health measure, second only to social dist...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833187/ https://www.ncbi.nlm.nih.gov/pubmed/33519950 http://dx.doi.org/10.1016/j.nantod.2021.101077 |
_version_ | 1783642008491917312 |
---|---|
author | Palmieri, Valentina De Maio, Flavio De Spirito, Marco Papi, Massimiliano |
author_facet | Palmieri, Valentina De Maio, Flavio De Spirito, Marco Papi, Massimiliano |
author_sort | Palmieri, Valentina |
collection | PubMed |
description | Coronavirus Disease 2019 (COVID-19) is one of the biggest challenges of the 21st century. While researchers are working on vaccine development and elucidating the mechanism of action and evolution of the harmful SARS-CoV-2, the current most important public health measure, second only to social distancing, is the obligatory wearing of facial protection. The Centers for Disease Control and Prevention recommended in April 2020 that the public wear face coverings in areas with high rates of transmission based on epidemiological evidence on the strong relationship between mask wearing and pandemic control. This protection against SARS-CoV-2 and other airborne pathogens, boost the design and production of innovative solutions by industry stakeholders. Nanoparticles, nanofibers, and other pioneering technologies based on nanomaterials have been introduced in mask production chains to improve performance and confer antiviral properties. During an emergency like COVID-19, these products directly available to the public should be carefully analyzed in terms of efficacy and possible long-term effects on the wearers’ skin and lungs as well as on the environment. This opinion paper provides a wealth of information on the role of nanotechnologies in improving the performance of facial masks and on possible future consequences caused by a poorly regulated use of nanotechnology in textiles. |
format | Online Article Text |
id | pubmed-7833187 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78331872021-01-26 Face masks and nanotechnology: Keep the blue side up Palmieri, Valentina De Maio, Flavio De Spirito, Marco Papi, Massimiliano Nano Today Opinion Coronavirus Disease 2019 (COVID-19) is one of the biggest challenges of the 21st century. While researchers are working on vaccine development and elucidating the mechanism of action and evolution of the harmful SARS-CoV-2, the current most important public health measure, second only to social distancing, is the obligatory wearing of facial protection. The Centers for Disease Control and Prevention recommended in April 2020 that the public wear face coverings in areas with high rates of transmission based on epidemiological evidence on the strong relationship between mask wearing and pandemic control. This protection against SARS-CoV-2 and other airborne pathogens, boost the design and production of innovative solutions by industry stakeholders. Nanoparticles, nanofibers, and other pioneering technologies based on nanomaterials have been introduced in mask production chains to improve performance and confer antiviral properties. During an emergency like COVID-19, these products directly available to the public should be carefully analyzed in terms of efficacy and possible long-term effects on the wearers’ skin and lungs as well as on the environment. This opinion paper provides a wealth of information on the role of nanotechnologies in improving the performance of facial masks and on possible future consequences caused by a poorly regulated use of nanotechnology in textiles. Elsevier Ltd. 2021-04 2021-01-13 /pmc/articles/PMC7833187/ /pubmed/33519950 http://dx.doi.org/10.1016/j.nantod.2021.101077 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Opinion Palmieri, Valentina De Maio, Flavio De Spirito, Marco Papi, Massimiliano Face masks and nanotechnology: Keep the blue side up |
title | Face masks and nanotechnology: Keep the blue side up |
title_full | Face masks and nanotechnology: Keep the blue side up |
title_fullStr | Face masks and nanotechnology: Keep the blue side up |
title_full_unstemmed | Face masks and nanotechnology: Keep the blue side up |
title_short | Face masks and nanotechnology: Keep the blue side up |
title_sort | face masks and nanotechnology: keep the blue side up |
topic | Opinion |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833187/ https://www.ncbi.nlm.nih.gov/pubmed/33519950 http://dx.doi.org/10.1016/j.nantod.2021.101077 |
work_keys_str_mv | AT palmierivalentina facemasksandnanotechnologykeepthebluesideup AT demaioflavio facemasksandnanotechnologykeepthebluesideup AT despiritomarco facemasksandnanotechnologykeepthebluesideup AT papimassimiliano facemasksandnanotechnologykeepthebluesideup |